Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News

February 4, 2019 – Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device ...

Home February 04, 2019
Home
Rivaroxaban is among four new oral anticoagulants (NOAC) now recommended by atrial fibrillation guidelines over the old standard of warfarin.
Feature | Atrial Fibrillation
January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral ...
Home January 30, 2019
Home
News | EP Mapping and Imaging Systems

January 28, 2019 — Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap ...

Home January 28, 2019
Home
Technology

January 21, 2019 — Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force ...

Home January 21, 2019
Home
News | Atrial Fibrillation

December 18, 2018 — Irish medical device company AuriGen Medical won the prestigious Global Innovation Award at the ...

Home December 18, 2018
Home
News

November 30, 2018 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and ...

Home November 30, 2018
Home
Videos | EP Lab

Wilber Su, M.D., chief of cardiac electrophysiology, Banner University Medical Center, Phoenix, and clinical associate ...

Home November 15, 2018
Home
Russel Pate, Ph.D., Univerity Of South Carolina, chair of the National Physical Activity Plan Alliance. #AHA18
Feature | AHA

November 7, 2018 — Here is a list of some of the key clinical trial presentations at the 2018 American Heart Association ...

Home November 20, 2018
Home
Technology

October 9, 2018 — Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA) for ...

Home October 09, 2018
Home
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Feature | ECG

Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the ...

Home September 27, 2018
Home
Feature | Atrial Fibrillation
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time ...
Home September 13, 2018
Home
News

August 28, 2018 — Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved ...

Home August 28, 2018
Home
News

July 13, 2018 — Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a ...

Home July 13, 2018
Home
News

July 5, 2018 — Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in ...

Home July 05, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

June 27, 2018 — Results from a 902-person, five-country survey of people living with atrial fibrillation (AF) reinforce ...

Home June 27, 2018
Home
Subscribe Now